Using light therapy to treat chronic cluster headaches
Official title: Proof-of-concept Study on the Efficacy of Light Therapy in the Prophylactic Treatment of Chronic Cluster Headache
Run by Assistance Publique Hopitaux De Marseille · NCT06540651 · Data updated 2026-11-12
This study is testing whether light therapy using a special device can help people with chronic cluster headaches feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | Assistance Publique Hopitaux De Marseille Academic / other |
| Locations | 2 sites (Marseille and 1 other locations) |
| Status | Recruiting |
| Started | February 6, 2025 |
| Main results expected | February 5, 2027 |
| Study ends | May 5, 2027 |
| Registry record updated | March 17, 2025 |
| Trial ID | NCT06540651 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a diagnosis of chronic cluster headache who are stable on their prophylactic treatment.
✕Probably not a fit
Patients with contraindications to light therapy or those with certain ophthalmological conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the efficacy of light therapy in patients suffering from chronic cluster headaches, a condition that is often challenging to manage. The approach involves using a consumer electronics device, Luminettes®, to deliver light therapy aimed at re-adjusting the chronobiological rhythms associated with this type of headache. Participants will be monitored for the prophylactic effects of this treatment compared to a control group receiving non-therapeutic light emission. The study aims to provide insights into a novel treatment option for this debilitating condition.
Why it matters
Potential benefit: If successful, this treatment could offer a new, non-invasive option for patients suffering from chronic cluster headaches.
How similar studies have gone: Previous studies have shown light therapy to be effective in treating other chronobiological conditions, suggesting potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, of 18 years years old or more; * Diagnosis of chronic cluster headache according to ICHD-3 criteria; * Number of seizures during baseline equal to at least 24; * Stability of prophylactic treatment for at least 1 month and commitment not to change it for the duration of the study; * Patient affiliated to the French social security system. * Patient who understands and speaks French correctly; * Patient who has given free and informed written consent. Exclusion Criteria: * Contraindication to the use of light therapy: use of a photosensitizing treatment; * Ophthalmological history: cataract, macular degeneration, glaucoma, retinitis pigmentosa; * Patients who work at night; * Other neurological, psychiatric or developmental pathologies considered incompatible with the study; * Background treatment of cluster headache with melatonin; * Persons protected by articles L1121-5, L1121-6 and L1121-8 of the French Public Health Code (pregnant or breast-feeding women, persons deprived of their liberty by judicial decision, socially vulnerable persons, adults incapable or unable to express their consent).
Where it's running
-
Hopital La Timone
Marseille, France Recruiting -
Hôpital de Cimiez
Nice, France Not yet recruiting
Study contacts
- Study coordinator: Anne DONNET
- Email: anne.donnet@ap-hm.fr
- Phone: +33491384345
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A real-world look at trigeminal autonomic cephalalgias in Italy
This study follows adults with TACs like cluster headache and related conditions in routine care to see how treatments work and what factors influence outcomes over time.
-
Magnesium sulfate for acute non-traumatic headache in the ED: 2 g vs 4 g vs standard paracetamol
This study tests whether intravenous magnesium sulfate given in different doses helps adults with acute non-traumatic headache in the emergency department, compared with paracetamol.
-
Noninvasive vagus nerve stimulation for prevention and treatment of primary headaches in children and teens
We will try a noninvasive ear-based vagus nerve stimulator to treat sudden primary headache attacks in children and adolescents aged 7–20.
-
Transcranial Direct Current Stimulation for Long COVID with Headaches and Chronic Pain
This study tests whether applying mild brain stimulation (tDCS) can help people with long COVID who have headaches, migraines, and ongoing pain.
-
Repeated GON injections for chronic cluster headache relief
This study is testing if repeated injections in the back of the head can help people with chronic cluster headaches have fewer headache attacks.
-
Registry for headache and vertigo conditions in China
This study is collecting information from people of all ages who have headaches or vertigo to see how different treatments work and how these conditions relate to other health issues.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.